This is a Validated Antibody Database (VAD) review about human IRF4, based on 55 published articles (read how Labome selects the articles), using IRF4 antibody in all methods. It is aimed to help Labome visitors find the most suited IRF4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
IRF4 synonym: LSIRF; MUM1; NF-EM5; SHEP8

Invitrogen
rat monoclonal (3E4)
  • flow cytometry; mouse; loading ...; fig 4c
Invitrogen IRF4 antibody (eBioscience, 48-9858-80) was used in flow cytometry on mouse samples (fig 4c). Cell Mol Gastroenterol Hepatol (2021) ncbi
rat monoclonal (3E4)
  • flow cytometry; mouse; 1:200; loading ...; fig 3b
Invitrogen IRF4 antibody (Ebioscience, 3E4) was used in flow cytometry on mouse samples at 1:200 (fig 3b). elife (2020) ncbi
rat monoclonal (3E4)
  • flow cytometry; mouse; loading ...; fig 1g
Invitrogen IRF4 antibody (ThermoFisher, 3E4) was used in flow cytometry on mouse samples (fig 1g). Blood Adv (2020) ncbi
rat monoclonal (3E4)
  • flow cytometry; mouse; 1:200; loading ...; fig 1h
Invitrogen IRF4 antibody (eBioscience, 46-9858-80) was used in flow cytometry on mouse samples at 1:200 (fig 1h). elife (2020) ncbi
rat monoclonal (3E4)
  • flow cytometry; mouse; 1:2000; loading ...; fig 7e
Invitrogen IRF4 antibody (eBioscience, 3E4) was used in flow cytometry on mouse samples at 1:2000 (fig 7e). elife (2019) ncbi
rat monoclonal (3E4)
  • flow cytometry; mouse; 1:300; loading ...; fig 2a
Invitrogen IRF4 antibody (ThermoFisher, 12-9858-80) was used in flow cytometry on mouse samples at 1:300 (fig 2a). Nat Commun (2019) ncbi
rat monoclonal (3E4)
  • flow cytometry; mouse; fig 3g
In order to study the involvement of RANKL in decidual M2 macrophage polarization, Invitrogen IRF4 antibody (ebioscience, 25-9858) was used in flow cytometry on mouse samples (fig 3g). Cell Death Dis (2017) ncbi
rat monoclonal (3E4)
  • flow cytometry; mouse; loading ...
In order to study the regulatory mechanism for the sex-dependent stroke mortality, Invitrogen IRF4 antibody (eBioscience, 3E4) was used in flow cytometry on mouse samples . Cell Immunol (2017) ncbi
rat monoclonal (3E4)
  • flow cytometry; human; loading ...; fig s14c
In order to map the lineage of human dendritic cells, Invitrogen IRF4 antibody (eBiosciences, 3E4) was used in flow cytometry on human samples (fig s14c). Science (2017) ncbi
rat monoclonal (3E4)
  • flow cytometry; mouse; loading ...; fig 3a
Invitrogen IRF4 antibody (eBioscience, 3E4) was used in flow cytometry on mouse samples (fig 3a). Immunology (2017) ncbi
rat monoclonal (3E4)
  • flow cytometry; human; loading ...; fig st12
In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, Invitrogen IRF4 antibody (eBioscience, 3E4) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi
rat monoclonal (3E4)
  • flow cytometry; mouse; loading ...
In order to demonstrate that DNMT3a directs early CD8 positive T-cell effector and memory fate decisions, Invitrogen IRF4 antibody (eBioscience, 3E4) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (3E4)
  • flow cytometry; mouse; loading ...; fig 2g
In order to propose that the ERK-AP-1 axis is important for translating TCR signal strength into proportional activation of downstream events, Invitrogen IRF4 antibody (eBiosciences, 46-9858-80) was used in flow cytometry on mouse samples (fig 2g). elife (2016) ncbi
rat monoclonal (3E4)
  • flow cytometry; mouse; fig s5
In order to show that the PTEN-mTORC2 axis maintains T regulatory cell stability and coordinates their control of effector responses, Invitrogen IRF4 antibody (eBioscience, 3E4) was used in flow cytometry on mouse samples (fig s5). Nat Immunol (2015) ncbi
rat monoclonal (3E4)
  • flow cytometry; mouse; 1:200
Invitrogen IRF4 antibody (eBiosciences, 3E4) was used in flow cytometry on mouse samples at 1:200. Cancer Res (2014) ncbi
rat monoclonal (3E4)
  • flow cytometry; rhesus macaque
Invitrogen IRF4 antibody (eBioscience, 3E4) was used in flow cytometry on rhesus macaque samples . Clin Immunol (2014) ncbi
BioLegend
rat monoclonal (IRF4.3E4)
  • flow cytometry; mouse; fig 4i
  • flow cytometry; human; loading ...; fig 4
BioLegend IRF4 antibody (BioLegend, IRF4.3F4) was used in flow cytometry on mouse samples (fig 4i) and in flow cytometry on human samples (fig 4). Aging Cell (2021) ncbi
rat monoclonal (IRF4.3E4)
  • flow cytometry; human; loading ...; fig 4b
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend IRF4 antibody (Biolegend, 646404) was used in flow cytometry on human samples (fig 4b) and in flow cytometry on mouse samples (fig 4b). Cell Rep (2019) ncbi
rat monoclonal (IRF4.3E4)
  • flow cytometry; human; 1:600; loading ...; fig 1f
BioLegend IRF4 antibody (Biolegend, 646403) was used in flow cytometry on human samples at 1:600 (fig 1f). elife (2019) ncbi
rat monoclonal (IRF4.3E4)
  • flow cytometry; mouse; 1:400; loading ...; fig ex2c
BioLegend IRF4 antibody (BioLegend, IRF4.3E4) was used in flow cytometry on mouse samples at 1:400 (fig ex2c). Nat Med (2019) ncbi
rat monoclonal (IRF4.3E4)
  • flow cytometry; mouse; loading ...; fig 8d
BioLegend IRF4 antibody (BioLegend, IRF4.3E4) was used in flow cytometry on mouse samples (fig 8d). Nat Commun (2018) ncbi
rat monoclonal (IRF4.3E4)
  • flow cytometry; mouse; loading ...; fig s9f
In order to investigate the similarity between interferon gamma-induced tumor ischemia and physiological blood vessel regression, BioLegend IRF4 antibody (BioLegend, 646408) was used in flow cytometry on mouse samples (fig s9f). Nature (2017) ncbi
rat monoclonal (IRF4.3E4)
  • flow cytometry; human; fig 7e
In order to assess the effects of lenalidomide on normal human plasma cell generation, BioLegend IRF4 antibody (BioLegend, IRF4.3E4) was used in flow cytometry on human samples (fig 7e). Oncotarget (2016) ncbi
rat monoclonal (IRF4.3E4)
  • flow cytometry; mouse; loading ...; fig 3a
  • immunocytochemistry; mouse; loading ...; fig 2e
In order to study the effect of atypical protein kinase C i on asymmetric division and CD8(+) T Lymphocyte, BioLegend IRF4 antibody (Biolegend, IRF4.3E4) was used in flow cytometry on mouse samples (fig 3a) and in immunocytochemistry on mouse samples (fig 2e). Sci Rep (2016) ncbi
Abcam
domestic rabbit monoclonal (EP5699)
  • western blot; human; loading ...; fig 4c
Abcam IRF4 antibody (Abcam, ab133590) was used in western blot on human samples (fig 4c). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (EP5699)
  • western blot; human; fig s5
Abcam IRF4 antibody (Abcam, ab133590) was used in western blot on human samples (fig s5). Clin Cancer Res (2016) ncbi
Miltenyi Biotec
human monoclonal (REA201)
  • flow cytometry; mouse; 1:20; fig 4c
Miltenyi Biotec IRF4 antibody (Miltenyi Biotec, 130-100-915) was used in flow cytometry on mouse samples at 1:20 (fig 4c). Nat Commun (2019) ncbi
Santa Cruz Biotechnology
mouse monoclonal (E-7)
  • chromatin immunoprecipitation; human; fig 3
Santa Cruz Biotechnology IRF4 antibody (Santa Cruz, sc-377383) was used in chromatin immunoprecipitation on human samples (fig 3). Ann Rheum Dis (2016) ncbi
rat monoclonal (3E4)
  • flow cytometry; mouse; fig 5
Santa Cruz Biotechnology IRF4 antibody (Santa Cruz Biotechnology, sc-130921) was used in flow cytometry on mouse samples (fig 5). Reprod Fertil Dev (2015) ncbi
Dako
mouse monoclonal (MUM1p)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 2c
Dako IRF4 antibody (Dako, M7259) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2c). BMC Cancer (2020) ncbi
mouse monoclonal (MUM1p)
  • immunohistochemistry - paraffin section; human; tbl 4
Dako IRF4 antibody (DakoCytomation, MUM1p) was used in immunohistochemistry - paraffin section on human samples (tbl 4). Ann Hematol (2017) ncbi
mouse monoclonal (MUM1p)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2e
  • immunohistochemistry; human; loading ...; fig 1e
In order to characterize three immunocompetent patients with primary cardiac diffuse large B-cell lymphoma, Dako IRF4 antibody (Dako, MUM1p) was used in immunohistochemistry - paraffin section on human samples (fig 2e) and in immunohistochemistry on human samples (fig 1e). Ann Diagn Pathol (2016) ncbi
mouse monoclonal (MUM1p)
  • immunohistochemistry - paraffin section; human; 1:50; tbl 2
In order to compare leukemic non-nodal mantle cell lymphoma with classical mantle cell lymphoma and aggressive mantle cell lymphoma, Dako IRF4 antibody (Dako, MUM1p) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 2). Virchows Arch (2016) ncbi
mouse monoclonal (MUM1p)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1a
In order to report that IgA-producing plasma cells are a major source of inducible NO synthase in Helicobacter pylori-infected patients, Dako IRF4 antibody (Dako, MUM1p) was used in immunohistochemistry - paraffin section on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (MUM1p)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2a
Dako IRF4 antibody (DAKO, MUM1P) was used in immunohistochemistry - paraffin section on human samples (fig 2a). Int J STD AIDS (2017) ncbi
mouse monoclonal (MUM1p)
  • immunohistochemistry - paraffin section; human; 1:100; fig 10
In order to characterize human lung cancer stroma for inflammatory and immune cell composition, Dako IRF4 antibody (Dako, Mum1p) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 10). PLoS ONE (2015) ncbi
mouse monoclonal (MUM1p)
  • immunohistochemistry - paraffin section; human; fig 3f
Dako IRF4 antibody (DAKO, MUM1p) was used in immunohistochemistry - paraffin section on human samples (fig 3f). Mod Pathol (2015) ncbi
mouse monoclonal (MUM1p)
  • immunohistochemistry; domestic horse; 1:25
In order to describe the lesions of six South African horses infected with West Nile virus, Dako IRF4 antibody (DakoCytomation, M7259) was used in immunohistochemistry on domestic horse samples at 1:25. J S Afr Vet Assoc (2014) ncbi
mouse monoclonal (MUM1p)
  • immunohistochemistry; human; 1:50
Dako IRF4 antibody (Dako, MUM1p) was used in immunohistochemistry on human samples at 1:50. Leuk Res (2015) ncbi
mouse monoclonal (MUM1p)
  • immunohistochemistry - paraffin section; human; 1:50
Dako IRF4 antibody (DAKO, MUM1p) was used in immunohistochemistry - paraffin section on human samples at 1:50. Int J Hematol (2015) ncbi
mouse monoclonal (MUM1p)
  • immunohistochemistry - paraffin section; human; 1:1500
Dako IRF4 antibody (Dako, M7259) was used in immunohistochemistry - paraffin section on human samples at 1:1500. PLoS ONE (2014) ncbi
mouse monoclonal (MUM1p)
  • immunohistochemistry - paraffin section; human; 1:25
Dako IRF4 antibody (Dako, MUM1p) was used in immunohistochemistry - paraffin section on human samples at 1:25. PLoS ONE (2014) ncbi
mouse monoclonal (MUM1p)
  • immunohistochemistry; human
Dako IRF4 antibody (Dako, MUM1P) was used in immunohistochemistry on human samples . Int J Hematol (2014) ncbi
mouse monoclonal (MUM1p)
  • immunohistochemistry; human; 1:25
Dako IRF4 antibody (Dako, M7259) was used in immunohistochemistry on human samples at 1:25. Blood Cancer J (2013) ncbi
mouse monoclonal (MUM1p)
  • immunohistochemistry; human; 1:20
In order to assess HIP1R expression patterns, study a mechanism of transcriptional regulation and determine its clinical relevance in patients with diffuse large B-cell lymphoma that are treated with immunochemotherapy, Dako IRF4 antibody (DAKO, MUM1p) was used in immunohistochemistry on human samples at 1:20. Leukemia (2014) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 3f
Cell Signaling Technology IRF4 antibody (Cell Signaling, 4964) was used in western blot on mouse samples at 1:1000 (fig 3f). J Immunother Cancer (2021) ncbi
domestic rabbit monoclonal (D43H10)
  • western blot; human; loading ...; fig 1g
Cell Signaling Technology IRF4 antibody (Cell Signaling Technology, 4299) was used in western blot on human samples (fig 1g). Sci Adv (2021) ncbi
domestic rabbit polyclonal
  • ChIP-Seq; human; 1-2 ug / 500 ul chr; loading ...; fig 4c
  • chromatin immunoprecipitation; human; loading ...; fig 4c
Cell Signaling Technology IRF4 antibody (Cell Signaling, 4964) was used in ChIP-Seq on human samples at 1-2 ug / 500 ul chr (fig 4c) and in chromatin immunoprecipitation on human samples (fig 4c). Cell Rep (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4d
Cell Signaling Technology IRF4 antibody (Cell Signaling, 4964) was used in western blot on human samples (fig 4d). Nature (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2a
Cell Signaling Technology IRF4 antibody (Cell Signaling Technology, 4964) was used in western blot on human samples (fig 2a). Blood Cancer J (2019) ncbi
domestic rabbit polyclonal
  • immunoprecipitation; mouse; loading ...; fig 2d
Cell Signaling Technology IRF4 antibody (Cell Signaling Technology., 4964S) was used in immunoprecipitation on mouse samples (fig 2d). Sci Adv (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 3f
In order to study the D. farinae allergen Pplase in a mouse model., Cell Signaling Technology IRF4 antibody (Cell Signaling, 4964) was used in western blot on mouse samples (fig 3f). Sci Rep (2017) ncbi
domestic rabbit monoclonal (D43H10)
  • chromatin immunoprecipitation; mouse; loading ...; fig 6a
In order to elucidate how Batf regulates Th2 immune responses, Cell Signaling Technology IRF4 antibody (Cell Signaling, D43H10) was used in chromatin immunoprecipitation on mouse samples (fig 6a). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 3
In order to study disruption of the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity due to immunomodulatory drugs, Cell Signaling Technology IRF4 antibody (Cell Signaling Technology, 4964) was used in western blot on human samples at 1:1000 (fig 3). Nat Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
In order to determine a therapeutic strategy to target the IRF4 network in multiple myeloma by using the bromodomain inhibition of the transcriptional coactivators CBP/EP300, Cell Signaling Technology IRF4 antibody (Cell Signaling Technology, 4964) was used in western blot on human samples (fig 4). elife (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
In order to determine a therapeutic strategy to target the IRF4 network in multiple myeloma by using the bromodomain inhibition of the transcriptional coactivators CBP/EP300, Cell Signaling Technology IRF4 antibody (Cell Signaling Technology, 4948) was used in western blot on human samples (fig 5). elife (2016) ncbi
Articles Reviewed
  1. Zheng J, Yao L, Zhou Y, Gu X, Wang C, Bao K, et al. A novel function of NLRP3 independent of inflammasome as a key transcription factor of IL-33 in epithelial cells of atopic dermatitis. Cell Death Dis. 2021;12:871 pubmed publisher
  2. Schanz O, Cornez I, Yajnanarayana S, David F, Peer S, Gruber T, et al. Tumor rejection in Cblb -/- mice depends on IL-9 and Th9 cells. J Immunother Cancer. 2021;9: pubmed publisher
  3. Liu J, Hideshima T, Xing L, Wang S, Zhou W, Samur M, et al. ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment. Sci Adv. 2021;7: pubmed publisher
  4. Go D, Lee S, Lee S, Woo S, Kim K, Kim K, et al. Programmed Death Ligand 1-Expressing Classical Dendritic Cells MitigateHelicobacter-Induced Gastritis. Cell Mol Gastroenterol Hepatol. 2021;12:715-739 pubmed publisher
  5. Webb L, Fra Bido S, Innocentin S, Matheson L, Attaf N, Bignon A, et al. Ageing promotes early T follicular helper cell differentiation by modulating expression of RBPJ. Aging Cell. 2021;20:e13295 pubmed publisher
  6. Xu A, Barbosa R, Calado D. Genetic timestamping of plasma cells in vivo reveals tissue-specific homeostatic population turnover. elife. 2020;9: pubmed publisher
  7. Witalis M, Chang J, Zhong M, Bouklouch Y, Panneton V, Li J, et al. Progression of AITL-like tumors in mice is driven by Tfh signature proteins and T-B cross talk. Blood Adv. 2020;4:868-879 pubmed publisher
  8. Cho I, Lee H, Yoon S, Ryu K, Ko Y, Kim W, et al. Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma. BMC Cancer. 2020;20:120 pubmed publisher
  9. Lee J, Zhang J, Chung Y, Kim J, Kook C, Gonzalez Navajas J, et al. Inhibition of IRF4 in dendritic cells by PRR-independent and -dependent signals inhibit Th2 and promote Th17 responses. elife. 2020;9: pubmed publisher
  10. Senigl F, Maman Y, Dinesh R, Alinikula J, Seth R, Pecnova L, et al. Topologically Associated Domains Delineate Susceptibility to Somatic Hypermutation. Cell Rep. 2019;29:3902-3915.e8 pubmed publisher
  11. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  12. Lynn R, Weber E, Sotillo E, Gennert D, Xu P, Good Z, et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature. 2019;576:293-300 pubmed publisher
  13. Leclerc M, Voilin E, Gros G, Corgnac S, de Montpreville V, Validire P, et al. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1. Nat Commun. 2019;10:3345 pubmed publisher
  14. Koike T, Harada K, Horiuchi S, Kitamura D. The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets. elife. 2019;8: pubmed publisher
  15. Zumaquero E, Stone S, Scharer C, Jenks S, Nellore A, Mousseau B, et al. IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation. elife. 2019;8: pubmed publisher
  16. Hammerich L, Marron T, Upadhyay R, Svensson Arvelund J, Dhainaut M, Hussein S, et al. Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination. Nat Med. 2019;25:814-824 pubmed publisher
  17. Zhu H, Bhatt B, Sivaprakasam S, Cai Y, Liu S, Kodeboyina S, et al. Ufbp1 promotes plasma cell development and ER expansion by modulating distinct branches of UPR. Nat Commun. 2019;10:1084 pubmed publisher
  18. Zhu Y, Shi C, Bruins L, Wang X, Riggs D, Porter B, et al. Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4. Blood Cancer J. 2019;9:19 pubmed publisher
  19. Li F, Zeng Z, Xing S, Gullicksrud J, Shan Q, Choi J, et al. Ezh2 programs TFH differentiation by integrating phosphorylation-dependent activation of Bcl6 and polycomb-dependent repression of p19Arf. Nat Commun. 2018;9:5452 pubmed publisher
  20. Chuang H, Tsai C, Hsueh C, Tan T. GLK-IKKβ signaling induces dimerization and translocation of the AhR-RORγt complex in IL-17A induction and autoimmune disease. Sci Adv. 2018;4:eaat5401 pubmed publisher
  21. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed publisher
  22. Shimono J, Miyoshi H, Kamimura T, Eto T, Miyagishima T, Sasaki Y, et al. Clinicopathological features of primary splenic follicular lymphoma. Ann Hematol. 2017;96:2063-2070 pubmed publisher
  23. Seifert H, Benedek G, Liang J, Nguyen H, Kent G, Vandenbark A, et al. Sex differences in regulatory cells in experimental stroke. Cell Immunol. 2017;318:49-54 pubmed publisher
  24. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  25. Kammertoens T, Friese C, Arina A, Idel C, Briesemeister D, Rothe M, et al. Tumour ischaemia by interferon-? resembles physiological blood vessel regression. Nature. 2017;545:98-102 pubmed publisher
  26. Meinicke H, Bremser A, Brack M, Akeus P, Pearson C, Bullers S, et al. Tumour-associated changes in intestinal epithelial cells cause local accumulation of KLRG1+ GATA3+ regulatory T cells in mice. Immunology. 2017;152:74-88 pubmed publisher
  27. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed publisher
  28. Wang H, Mo L, Xiao X, An S, Liu X, Ba J, et al. Pplase of Dermatophagoides farinae promotes ovalbumin-induced airway allergy by modulating the functions of dendritic cells in a mouse model. Sci Rep. 2017;7:43322 pubmed publisher
  29. Soon G, Ow G, Chan H, Ng S, Wang S. Primary cardiac diffuse large B-cell lymphoma in immunocompetent patients: clinical, histologic, immunophenotypic, and genotypic features of 3 cases. Ann Diagn Pathol. 2016;24:40-6 pubmed publisher
  30. Gallo M, Cacheux V, Vincent L, Bret C, Tempier A, Guittard C, et al. Leukemic non-nodal mantle cell lymphomas have a distinct phenotype and are associated with deletion of PARP1 and 13q14. Virchows Arch. 2016;469:697-706 pubmed
  31. Ladle B, Li K, Phillips M, Pucsek A, Haile A, Powell J, et al. De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8+ T-cell fate decisions following activation. Proc Natl Acad Sci U S A. 2016;113:10631-6 pubmed publisher
  32. Kuwahara M, Ise W, Ochi M, Suzuki J, Kometani K, Maruyama S, et al. Bach2-Batf interactions control Th2-type immune response by regulating the IL-4 amplification loop. Nat Commun. 2016;7:12596 pubmed publisher
  33. Neumann L, Mueller M, Moos V, Heller F, Meyer T, Loddenkemper C, et al. Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients. J Immunol. 2016;197:1801-8 pubmed publisher
  34. Allison K, Sajti E, Collier J, Gosselin D, Troutman T, Stone E, et al. Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4+ T cells. elife. 2016;5: pubmed publisher
  35. Eichner R, Heider M, Fernández Sáiz V, van Bebber F, Garz A, Lemeer S, et al. Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity. Nat Med. 2016;22:735-43 pubmed publisher
  36. Wang D, Zheng Y, Zeng D, Yang Y, Zhang X, Feng Y, et al. Clinicopathologic characteristics of HIV/AIDS-related plasmablastic lymphoma. Int J STD AIDS. 2017;28:380-388 pubmed publisher
  37. Jourdan M, Cren M, Schafer P, Robert N, Duperray C, Vincent L, et al. Differential effects of lenalidomide during plasma cell differentiation. Oncotarget. 2016;7:28096-111 pubmed publisher
  38. Vieyra Garcia P, Wei T, Naym D, Fredholm S, Fink Puches R, Cerroni L, et al. STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides. Clin Cancer Res. 2016;22:3328-39 pubmed publisher
  39. Metz P, Lopez J, Kim S, Akimoto K, Ohno S, Chang J. Regulation of Asymmetric Division by Atypical Protein Kinase C Influences Early Specification of CD8(+) T Lymphocyte Fates. Sci Rep. 2016;6:19182 pubmed publisher
  40. Conery A, Centore R, Neiss A, Keller P, Joshi S, Spillane K, et al. Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma. elife. 2016;5: pubmed publisher
  41. Vecellio M, Roberts A, Cohen C, Cortes A, Knight J, Bowness P, et al. The genetic association of RUNX3 with ankylosing spondylitis can be explained by allele-specific effects on IRF4 recruitment that alter gene expression. Ann Rheum Dis. 2016;75:1534-40 pubmed publisher
  42. Banat G, Tretyn A, Pullamsetti S, Wilhelm J, Weigert A, Olesch C, et al. Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma. PLoS ONE. 2015;10:e0139073 pubmed publisher
  43. Ribera Cortada I, Martinez D, Amador V, Royo C, Navarro A, Beà S, et al. Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype. Mod Pathol. 2015;28:1435-47 pubmed publisher
  44. Wang J, Yin T, Wen Y, Tian F, He X, Zhou D, et al. Potential effects of interferon regulatory factor 4 in a murine model of polyinosinic-polycytidylic acid-induced embryo resorption. Reprod Fertil Dev. 2015;: pubmed publisher
  45. Williams J, van Niekerk S, Human S, van Wilpe E, Venter M. Pathology of fatal lineage 1 and 2 West Nile virus infections in horses in South Africa. J S Afr Vet Assoc. 2014;85:1105 pubmed publisher
  46. Shrestha S, Yang K, Guy C, Vogel P, Neale G, Chi H. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat Immunol. 2015;16:178-87 pubmed publisher
  47. Song M, Chung J, Lee G, Cho S, Hong J, Shin D, et al. Statin use has negative clinical impact on non-germinal center in patients with diffuse large B cell lymphoma in rituximab era. Leuk Res. 2015;39:211-5 pubmed publisher
  48. Song M, Chung J, Lee J, Yang D, Kim I, Shin D, et al. High Ki-67 expression in involved bone marrow predicts worse clinical outcome in diffuse large B cell lymphoma patients treated with R-CHOP therapy. Int J Hematol. 2015;101:140-7 pubmed publisher
  49. Knutson S, Warholic N, Johnston L, Klaus C, Wigle T, Iwanowicz D, et al. Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas. PLoS ONE. 2014;9:e111840 pubmed publisher
  50. Chatterjee S, Thyagarajan K, Kesarwani P, Song J, Soloshchenko M, Fu J, et al. Reducing CD73 expression by IL1?-Programmed Th17 cells improves immunotherapeutic control of tumors. Cancer Res. 2014;74:6048-59 pubmed publisher
  51. Bellas C, Garcia D, Vicente Y, Kilany L, Abraira V, Navarro B, et al. Immunohistochemical and molecular characteristics with prognostic significance in diffuse large B-cell lymphoma. PLoS ONE. 2014;9:e98169 pubmed publisher
  52. Demberg T, Mohanram V, Venzon D, Robert Guroff M. Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model. Clin Immunol. 2014;153:264-76 pubmed publisher
  53. Li Y, Yimamu M, Wang X, Zhang X, Mao M, Fu L, et al. Addition of rituximab to a CEOP regimen improved the outcome in the treatment of non-germinal center immunophenotype diffuse large B cell lymphoma cells with high Bcl-2 expression. Int J Hematol. 2014;99:79-86 pubmed publisher
  54. Caramuta S, Lee L, Ozata D, Akçakaya P, Georgii Hemming P, Xie H, et al. Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma. Blood Cancer J. 2013;3:e152 pubmed publisher
  55. Wong K, Gascoyne D, Brown P, Soilleux E, Snell C, Chen H, et al. Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients. Leukemia. 2014;28:362-72 pubmed publisher